Glymphatic Function and White Matter Integrity in Cerebral Venous Disorders

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorXuanwu Hospital, Beijing

About this trial

Cerebral venous disorders, including cerebral venous sinus stenosis (CVSS) and cerebral venous sinus thrombosis (CVST), can obstruct venous blood drainage, leading to intracranial hypertension. However, their effects on glymphatic function and white matter integrity in the brain remain poorly understood.

Therefore, this study will enroll healthy controls, CVSS patients, and CVST patients to compare differences in glymphatic function and white matter microstructural integrity. Additionally, CVSS and CVST patients will undergo a 3-month follow-up to investigate the interrelationships and longitudinal changes among clinical parameters, glymphatic function, and white matter integrity.

Eligibility criteria

Qualifiers

Subjects with Cerebral Venous Sinus Stenosis

Age ≥18 years, any gender;

Definite diagnosis of cerebral venous sinus stenosis confirmed by clinical and imaging examinations;

Stenosis limited to the transverse sinus and/or sigmoid sinus, presenting as moderate to severe localized stenosis or occlusion (stenosis degree ≥50%), with or without internal jugular vein stenosis;

Disqualifiers

Simple anatomical variation or physiological narrowing of the cerebral venous sinus/internal jugular vein without definitive evidence of localized stenosis;

Complicated by cerebral venous sinus/cortical vein/internal jugular vein thrombosis;

Prior receipt of endovascular treatment for cerebral venous sinus/internal jugular vein, ventricular puncture drainage, or lumbar cistern drainage before enrollment;

Presence of moderate to severe stenosis (≥50%) in intracranial or extracranial arteries;

Trial design

Treatments tested in this trial

  • Baseline and 3-month follow-up
  • Baseline

Treatment groups

149 Participants
are divided into 3 treatment groups

Sponsors and collaborators